Waterstone Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Waterstone Pharmaceuticals's estimated annual revenue is currently $4.6M per year.
- Waterstone Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Waterstone Pharmaceuticals has 23 Employees.
- Waterstone Pharmaceuticals grew their employee count by 0% last year.
Waterstone Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
Waterstone Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.6M | 23 | 0% | N/A | N/A |
#2 | $23.5M | 117 | -28% | N/A | N/A |
#3 | $575.7M | 2864 | 2% | N/A | N/A |
#4 | $1.8M | 18 | -10% | $1.5M | N/A |
#5 | $5.8M | 29 | -6% | N/A | N/A |
#6 | $10.7M | 53 | 15% | N/A | N/A |
#7 | $271.4M | 1350 | 4% | N/A | N/A |
#8 | $9.2M | 46 | 10% | N/A | N/A |
#9 | $27760M | 44397 | 4% | N/A | N/A |
#10 | $1.2M | 6 | -54% | N/A | N/A |
What Is Waterstone Pharmaceuticals?
Based in Indianapolis, IN with operations in Wuhan, China, Waterstone Pharmaceuticals is an emerging leader in providing products and services to the global life sciences industry. In 2010, Waterstone Pharmaceuticals launched its new R&D center and new API manufacturing facility meeting ICH Q7 and US FDA cGMP guidelines. From early stage discovery to commercial programs, Waterstone Pharmaceuticals continues to invest into technologies and capabilities to serve the global pharmaceutical industry. o Catalog of over 30,000 research products o Custom synthesis o Custom development and manufacturing o non GMP and cGMP advanced starting materials o cGMP APIs
keywords:N/AN/A
Total Funding
23
Number of Employees
$4.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 23 | 10% | N/A |
#2 | $2.3M | 23 | -12% | N/A |
#3 | $2.8M | 24 | 9% | N/A |
#4 | $2M | 24 | 0% | N/A |
#5 | $4.2M | 24 | -29% | N/A |